May 2, 2018 by Chain Drug Review
Aetna Inc., CVS Health, CVS-Aetna, Larry Merlo, PBMs, pharmacy
Business, Featured Articles, Leading Headlines, Retail News
WOONSOCKET, R.I. — CVS Health’s revenue was on the rise as it filled more prescriptions and benefited from a lower effective tax rate, the company said today in reporting its operating results for the three months ended March 31. The drug store chain said its first quarter revenue increased 2.6% to $45.7 billion from $44.5
March 13, 2018 by Chain Drug Review
Aetna, Amazon, Berskhire Hathaway, Cigna, CVS Health, CVS-Aetna merger, Express Scripts, JPMorgan Chase, Larry Merlo, Mark Bertolini, UnitedHealth Group
Business, Featured Articles, Leading Headlines, Pharmacy, Retail News
WOONSOCKET, R.I. — Shareholders of CVS Health voted overwhelmingly to approve the company’s $69 billion deal to acquire health insurer Aetna Inc. CVS said that in a special stockholders meeting on Tuesday, more than 98% of shares were voted in favor of the CVS-Aetna merger agreement, which was announced in early December. Also at a
February 20, 2018 by Chain Drug Review
2018 Fast Company 50 Most Innovative Companies list, CVS Health, Fast Company, Larry Merlo, Walmart
Leading Headlines, Retail News
NEW YORK — CVS Health and Walmart have been named to the 2018 Fast Company 50 Most Innovative Companies list. On this year’s 50 Most Innovative Companies listing, CVS finished in the top 10, coming in at No. 7 for “cleaning up the aisles,” Fast Company said. CVS had last made the list in 2016,
February 8, 2018 by Chain Drug Review
CVS Health, CVS Pharmacy, David Denton, Larry Merlo, Tax Cuts & Jobs Act, TCJA
Business, Featured Articles, Leading Headlines, Retail News
WOONSOCKET, R.I. — Driven by growth in its pharmacy benefit management unit, and overcoming softness in its retail business, CVS Health posted increased sales and beat Wall Street’s earnings forecast for its 2017 fourth quarter and fiscal year. CVS said Thursday that for the fourth quarter ended Dec. 31, total revenue rose 5.3% to $48.39
January 17, 2018 by Chain Drug Review
2018 Retail Forecast, Albertsons, Alex Gourlay, AmerisourceBergen, Brian Nightengale, Cardinal Health, Care Pharmacies, Carmen Churcott, Chris Dimos, CVS Health, Discount Drug Mart, Fruth Pharmacy, Genoa, Good Neighbor Pharmacy, Hy-Vee, Jeff Leger, John Figueroa, John Standley, Kristin Williams, Larry Merlo, Lynne Fruth, Mark Panzer, McKesson, Medicine Shoppe, Michael Wysong, Mike Eby, Pharmaca, Pharmasave, Richard Willis, Rite Aid, Robert Mauch, Shoppers Drug Mart, Steve Lawrence, Todd Treon, Walgreens Boots Alliance
Featured Articles, Leading Headlines, Pharmacy, Retail News
What will the second year of the Trump administration look like? Is the demise of the Affordable Care Act imminent? Will pharmacists get the greater role in health care they have long sought? These are among the questions top chain drug industry executives are pondering as they look to 2018. With spiraling health care costs and
January 15, 2018 by Scot Meyer and Chain Drug Review
CVS Health, CVS Health's 2018 earnings outlook, David Denton, Larry Merlo, Red Oak
2018, Issue 01-15-2018, Issues, News
WOONSOCKET, R.I. — CVS Health executives expressed confidence in the company’s growth strategy earlier this month, and also noted that the recently passed tax overhaul packaged should boost its cash flow by an estimated $1.2 billion. The remarks came in a conference call following an announcement of CVS Health’s 2018 earnings outlook. CVS Health said
January 5, 2018 by Scot Meyer and Chain Drug Review
CVS Health, CVS Pharmacy, David Denton, Larry Merlo, Red Oak
Business, Leading Headlines, Retail News
WOONSOCKET, R.I. — In an update for investors, CVS Health executives expressed confidence in its growth outlook and noted that the recently passed tax overhaul package should boost its cash flow by an estimated $1.2 billion. The remarks came yesterday in a conference call after the company’s announcement of its earnings expectations for 2018. CVS
January 1, 2018 by Jeffrey Woldt and Chain Drug Review
Aetna, Affordable Care Act, CVS Health, CVS-Aetna merger, Jeffrey Woldt, Larry Merlo, Matthew Shay, National Retail Federation, Rite Aid, Tax Cuts and Jobs Act, Walgreens Boots Alliance
2018, Issue 01-01-2018, Issues, Opinion
A case could be made that for pharmacy operators passage of the Tax Cuts and Jobs Act late last month was the biggest story of 2017. Championed by the Republican leadership in Congress and President Trump, the $1.5 trillion measure will provide substantial, permanent tax relief for businesses — the corporate tax rate was cut
December 14, 2017 by Chain Drug Review
CVS Health, CVS Pharmacy, CVS-Aetna merger, Larry Merlo, National Public Radio, NPR, Steve Inskeep
Featured Articles, Leading Headlines, Pharmacy, Retail News
NEW YORK — Acquiring Aetna Inc. will better position CVS Health to improve health outcomes and bring affordable health care to more Americans, CVS president and chief executive officer Larry Merlo told National Public Radio (NPR). The addition of a health insurer like Aetna will allow CVS to provide a more comprehensive care offering to
December 11, 2017 by Bill Schiffner
Aetna, Amazon, Brian Tanquilut, CVS Health, CVS Pharmacy, CVS-Aetna merger, Jefferies, Larry Merlo, Mark Bertolini, MinuteClinic
2017, Issue 12-11-2017, Issues, News
WOONSOCKET, R.I. — CVS Health plans to acquire health insurer Aetna for roughly $69 billion in a first-of-its kind deal aimed at fending off challenges in retail and health care. The landmark CVS-Aetna merger deal comes at time when insurers are under pressure to lower medical costs, and retailers are under attack from new competitors,
December 3, 2017 by Chain Drug Review
Aetna, CVS Caremark, CVS Health, CVS Pharmacy, CVS-Aetna merger, Larry Merlo, Mark Bertolini, MinuteClinic
Business, Featured Articles, Leading Headlines, Retail News
WOONSOCKET, R.I., and HARTFORD, Conn. — Following mounting speculation over the past month, CVS Health has unveiled a cash-and stock-deal to acquire health insurer Aetna Inc. for $69 billion. CVS and Aetna said Sunday evening that under the merger pact, Aetna shareholders will receive about $207 per share, including $145 in cash and 0.8378 CVS
November 6, 2017 by Chain Drug Review
CVS Health, CVS Pharmacy, CVS third-quarter sales, Larry Merlo
Business, Featured Articles, Leading Headlines, Retail News
WOONSOCKET, R.I. — Despite sales declines in its retail pharmacy business, CVS Health saw overall revenue rise and bested Wall Street’s earnings forecast for its fiscal 2017 third quarter. CVS said Monday that for the third quarter ended Sept. 30, sales totaled $46.18 billion up 3.5% from $44.62 billion a year earlier. CVS third-quarter sales
November 6, 2017 by Geoff Walden and Chain Drug Review
Alex Gourlay, Anthem, CVS Caremark PBM, CVS Pharmacy, Express Scripts, Helena Foulkes, IngenioRx, Jon Roberts, Joseph Swedish, Larry Merlo, performance pharmacy network, pharmacy benefit management, Walgreens
2017, Issue 11-06-2017, Issues, News
WOONSOCKET, R.I. — CVS Health has announced two major agreements to boost pharmacy benefit management services. The company late last month introduced a 30,000-store performance-based pharmacy network anchored by CVS Pharmacy and Walgreens designed to deliver savings and improved clinical outcomes for CVS Caremark PBM members. That followed the company’s announcement of a five-year deal
November 6, 2017 by Bill Schiffner
Adam Fein, Aetna, Amazon, CVS Caremark, CVS Health, CVS Pharmacy, CVS-Aetna deal, Humana, Larry Merlo, Mark Bertolini, MinuteClinic, OptumRx, Pembroke Consulting, UnitedHealth
2017, Issue 11-06-2017, Issues, News
WOONSOCKET, R.I. — At presstime The Wall Street Journal along with other news agencies reported that CVS Health will offer more than $200 per share, or about $66 billion, to purchase the health insurance giant Aetna Inc. Anonymous sources cited by WSJ originated the story about a potential CVS-Aetna deal. The possible transaction comes as